Medtronic Plc is a healthcare technology company. The company operates through four segments – Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes. These segments develop, manufacture, distribute, and sell device-based medical therapies and services. The Cardiovascular Portfolio segment includes cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions. The cardiac rhythm and heart failure division consists of cardiac rhythm management, cardiac ablation solutions, and cardiovascular diagnostics and services. Its products include implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), products that reduce surgical site infections, information systems for the management of patients with cardiac rhythm and heart failure devices, and an integrated health solutions business. Structural heart & aortic division includes therapies to treat heart valve disorders and aortic disease. Its devices comprise products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, surgical ablation products, and a comprehensive line of products and therapies to treat aortic diseases such as aneurysms, dissections, and transections. The coronary and peripheral vascular division offers products and therapies to treat coronary artery disease, peripheral vascular disease, and venous disease. It offers products such as coronary stents and related delivery systems including balloon angioplasty catheters, guide catheters, guide wires, diagnostic catheters, and accessories, peripheral drug-coated balloons, stent and angioplasty systems, carotid embolic protection systems for the treatment of vascular disease outside the heart, and products for superficial and deep venous disease.

The Medical Surgical Portfolio segment consists of the surgical innovations and respiratory, gastrointestinal, and renal divisions. The Neuroscience Portfolio segment includes cranial and spinal technologies, speciality therapies, and neuromodulation divisions. The company’s Diabetes segment develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes. Principal products include insulin pumps and consumables, including the MiniMed 770G system and MiniMed 780G system.